Ipsen (IPN-1087) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Ipsen (IPN-1087) General Information
Description
Intellectual property and assets related to IPN-1087.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- Boulogne-Billancourt
- France
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Biotechnology
Acquirer
Vertical(s)
Corporate Office
- Boulogne-Billancourt
- France
Ipsen (IPN-1087) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ipsen (IPN-1087) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ipsen (IPN-1087) FAQs
-
Where is Ipsen (IPN-1087) headquartered?
Ipsen (IPN-1087) is headquartered in Boulogne-Billancourt, France.
-
What industry is Ipsen (IPN-1087) in?
Ipsen (IPN-1087)’s primary industry is Buildings and Property.
-
Is Ipsen (IPN-1087) a private or public company?
Ipsen (IPN-1087) is a Private company.
-
What is Ipsen (IPN-1087)’s current revenue?
The current revenue for Ipsen (IPN-1087) is .
-
Who are Ipsen (IPN-1087)’s investors?
Ipsen has invested in Ipsen (IPN-1087).
-
When was Ipsen (IPN-1087) acquired?
Ipsen (IPN-1087) was acquired on 01-Apr-2021.
-
Who acquired Ipsen (IPN-1087)?
Ipsen (IPN-1087) was acquired by Fusion Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process